Lhermitte-Duclos disease: Difference between revisions
Jump to navigation
Jump to search
Line 19: | Line 19: | ||
{{SK}} Dysplastic cerebellar gangliocytoma | {{SK}} Dysplastic cerebellar gangliocytoma | ||
== Overview == | == Overview == | ||
In The United States of America in order to categorise a condition is a [[rare disease]] it should affect fewer than 200,000 people. [[Rare diseases]] also called as [[Orphan disease|orphan diseases]]. Orphan Drug Act was passed on 1983 by congress for the [[rare diseases]]. Today an average of 25-30 million americans have been reported with [[rare diseases]]. The number of people with individual [[rare disease]] may be less but overall the number of people with [[rare diseases]] are large in number. | |||
== Historical Perspective == | == Historical Perspective == |
Revision as of 13:27, 16 April 2019
Lhermitte-Duclos disease | |
OMIM | 158350 |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Dysplastic cerebellar gangliocytoma
Overview
In The United States of America in order to categorise a condition is a rare disease it should affect fewer than 200,000 people. Rare diseases also called as orphan diseases. Orphan Drug Act was passed on 1983 by congress for the rare diseases. Today an average of 25-30 million americans have been reported with rare diseases. The number of people with individual rare disease may be less but overall the number of people with rare diseases are large in number.